Table 4 Clinical predictor of malignancy for patient undergoing surgical biopsy of solitary nodules
Clinical feature | Number of patients | Number of malignancy (%) | OR (95 % CI) | P value |
|---|---|---|---|---|
Male | 91 | 51/91 (56 %) | 0.70 (0.42–3.63) | 0.39 |
>60 year-old | 109 | 77/109 (70.6 %) | 2.40 (1.59–3.63) | 0.0001 |
Tobacco abuse | 111 | 64/111 (57.7 %) | 0.85 (0.46–1.57) | 0.61 |
Prior malignancy | 107 | 82/107 (76.6 %) | 6.43 (3.33–12.4) | 0.00001 |
Size > 10 mm | 60 | 47/60 (78 %) | 3.61 (1.95–6.61) | 0.0001 |
Superior lobe | 91 | 63/91 (69.2 %) | 2.35 (1.28–4.31) | 0.0052 |
PET-positive | 82/110 | 66/82 (80.5 %) | 5.83 (2.96–11.48) | 0.00001 |